TCG Crossover Management’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$49.4M Hold
5,319,148
5.64% 4
2025
Q1
$39M Hold
5,319,148
5.32% 5
2024
Q4
$45.4M Hold
5,319,148
4.44% 6
2024
Q3
$46.3M Hold
5,319,148
3.92% 12
2024
Q2
$36.4M Hold
5,319,148
3.79% 11
2024
Q1
$48.4M Buy
+5,319,148
New +$48.4M 3.83% 11